{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:31:05Z","timestamp":1792787465451,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)","award":["307687\/2009-0"],"award-info":[{"award-number":["307687\/2009-0"]}],"id":[{"id":"https:\/\/ror.org\/03swz6y49","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de Ensino Superior (CAPES)"},{"name":"Rede Instituto Brasileiro de Neuroci\u00eancias (IBN-Net\/CNPq)","award":["01.06.0842-00"],"award-info":[{"award-number":["01.06.0842-00"]}]},{"name":"NENASC Project (PRONEX-FAPESC\/CNPq)","award":["1262\/2012-9"],"award-info":[{"award-number":["1262\/2012-9"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.pbb.2014.10.003","type":"journal-article","created":{"date-parts":[[2014,10,12]],"date-time":"2014-10-12T17:08:34Z","timestamp":1413133714000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Folic acid prevents depressive-like behavior induced by chronic corticosterone treatment in mice"],"prefix":"10.1016","volume":"127","author":[{"given":"Priscila B.","family":"Rosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille M.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E.B.","family":"Bettio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Colla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Lieberknecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgana","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L\u00facia S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2014.10.003_bb0005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jpsychores.2006.07.007","article-title":"Folic acid and the treatment of depression","volume":"61","author":"Abou-Saleh","year":"2006","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.pbb.2014.10.003_bb0010","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.neuropharm.2008.08.026","article-title":"Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression","volume":"55","author":"Ago","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2014.10.003_bb0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuropharm.2012.09.008","article-title":"Metabotropic glutamate 2\/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice","volume":"65","author":"Ago","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2014.10.003_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2008.08.033","article-title":"Antidepressant-like effect of folic acid: involvement of NMDA receptors and l-arginine\u2013nitric oxide\u2013cyclic guanosine monophosphate pathway","volume":"598","author":"Brocardo","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2014.10.003_bb0025","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.neuropharm.2007.10.016","article-title":"Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems","volume":"54","author":"Brocardo","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2014.10.003_bb0030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbr.2009.01.004","article-title":"Evidence for the involvement of the opioid system in the antidepressant-like effect of folic acid in the mouse forced swimming test","volume":"200","author":"Brocardo","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2014.10.003_bb0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pbb.2011.12.008","article-title":"Role of potassium channels in the antidepressant-like effect of folic acid in the forced swimming test in mice","volume":"101","author":"Budni","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2014.10.003_bb0040","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/0269881111424456","article-title":"Involvement of PI3K, GSK-3beta and PPARgamma in the antidepressant-like effect of folic acid in the forced swimming test in mice","volume":"26","author":"Budni","year":"2012","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2014.10.003_bb0045","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.expneurol.2012.10.024","article-title":"Folic acid prevents depressive-like behavior and hippocampal antioxidant imbalance induced by restraint stress in mice","volume":"240","author":"Budni","year":"2013","journal-title":"Exp Neurol"},{"issue":"Suppl. 3","key":"10.1016\/j.pbb.2014.10.003_bb0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1468-3083.2012.04522.x","article-title":"Topical corticosteroids in plaque psoriasis: a systematic review of efficacy and treatment modalities","volume":"26","author":"Castela","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.pbb.2014.10.003_bb0055","doi-asserted-by":"crossref","first-page":"506735","DOI":"10.1155\/2014\/506735","article-title":"Ginseng total saponins reverse corticosterone-induced changes in depression-like behavior and hippocampal plasticity-related proteins by interfering with GSK-3 beta\u2013CREB signaling pathway","volume":"2014","author":"Chen","year":"2014","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.pbb.2014.10.003_bb0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2014.10.003_bb0065","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.npp.1300875","article-title":"Sexually dimorphic responses of the brain norepinephrine system to stress and corticotropin-releasing factor","volume":"31","author":"Curtis","year":"2006","journal-title":"Neuropsychopharm"},{"key":"10.1016\/j.pbb.2014.10.003_bb0070","first-page":"119","article-title":"Effects of corticosterone ingestion on hippocampal [(3)H]serotonin reuptake in inbred rat strains","volume":"35","author":"Fernandez","year":"2001","journal-title":"Endocr Regul"},{"key":"10.1016\/j.pbb.2014.10.003_bb0075","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/sj.mp.4001032","article-title":"Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH\/NE states","volume":"7","author":"Gold","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pbb.2014.10.003_bb0080","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1749-6632.1995.tb44723.x","article-title":"Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs","volume":"771","author":"Gold","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pbb.2014.10.003_bb0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2004.05.013","article-title":"Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats","volume":"156","author":"Gregus","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2014.10.003_bb0090","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.clinpsy.1.102803.143938","article-title":"Stress and depression","volume":"1","author":"Hammen","year":"2005","journal-title":"Annu Rev Clin Psychol"},{"key":"10.1016\/j.pbb.2014.10.003_bb0095","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0006-3223(01)01157-X","article-title":"The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies","volume":"49","author":"Heim","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2014.10.003_bb0100","doi-asserted-by":"crossref","first-page":"e20198","DOI":"10.1371\/journal.pone.0020198","article-title":"Long-term continuous corticosterone treatment decreases VEGF receptor-2 expression in frontal cortex","volume":"6","author":"Howell","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2014.10.003_bb0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2010.08.078","article-title":"Pharmacological characterization of repeated corticosterone injection-induced depression model in rats","volume":"1359","author":"Iijima","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2014.10.003_bb0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0278-5846(95)00299-5","article-title":"Effects of acute and chronic administration of high-dose corticosterone and dexamethasone on regional brain dopamine and serotonin metabolism in rats","volume":"20","author":"Inoue","year":"1996","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2014.10.003_bb0115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbr.2005.11.019","article-title":"Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor","volume":"168","author":"Johnson","year":"2006","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2014.10.003_bb0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1590\/S1516-44462004000300009","article-title":"The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression","volume":"26","author":"Juruena","year":"2004","journal-title":"Rev Bras Psiquiatr"},{"key":"10.1016\/j.pbb.2014.10.003_bb0125","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.biopsych.2005.10.014","article-title":"Cortisol circadian rhythm alterations in psychotic major depression","volume":"60","author":"Keller","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2014.10.003_bb0130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/156652409787847146","article-title":"Folic acid, neurodegenerative and neuropsychiatric disease","volume":"9","author":"Kronenberg","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.pbb.2014.10.003_bb0135","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/endo-105-3-812","article-title":"Temporal changes in plasma adrenocorticotropin concentration after repeated neurotropic stress in male and female rats","volume":"105","author":"Le Mevel","year":"1979","journal-title":"Endocrinology"},{"key":"10.1016\/j.pbb.2014.10.003_bb0140","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1039\/c3fo60246j","article-title":"Nutritional strategies for dealing with depression","volume":"4","author":"Manosso","year":"2013","journal-title":"Food Funct"},{"key":"10.1016\/j.pbb.2014.10.003_bb0150","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbr.2011.07.024","article-title":"Involvement of nitric oxide\u2013cGMP pathway in the antidepressant-like effect of ascorbic acid in the tail suspension test","volume":"225","author":"Moretti","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2014.10.003_bb0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jpsychires.2011.11.009","article-title":"Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress","volume":"46","author":"Moretti","year":"2012","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pbb.2014.10.003_bb0155","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/acm.2007.0663","article-title":"Folate and unipolar depression","volume":"14","author":"Morris","year":"2008","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.pbb.2014.10.003_bb0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cpr.2012.02.002","article-title":"Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis","volume":"32","author":"Morris","year":"2012","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.pbb.2014.10.003_bb0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jpsychires.2006.05.008","article-title":"The burden of severe depression: a review of diagnostic challenges and treatment alternatives","volume":"41","author":"Nemeroff","year":"2007","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pbb.2014.10.003_bb0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1520-6394(1998)8:1+<71::AID-DA11>3.0.CO;2-X","article-title":"Depression and cardiac disease","volume":"1","author":"Nemeroff","year":"1998","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pbb.2014.10.003_bb0175","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2014.10.003_bb0180","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1358\/dot.2013.49.12.2086138","article-title":"Folate augmentation of antidepressant response","volume":"49","author":"Owen","year":"2013","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.pbb.2014.10.003_bb0185","doi-asserted-by":"crossref","DOI":"10.1017\/S1461145705005195","article-title":"The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine","volume":"8","author":"Papakostas","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2014.10.003_bb0190","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1176\/appi.ajp.2012.11071114","article-title":"l-Methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials","volume":"169","author":"Papakostas","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2014.10.003_bb0195","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.psychres.2012.01.029","article-title":"Serum cortisol concentration in patients with major depression after treatment with fluoxetine","volume":"198","author":"Piwowarska","year":"2012","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pbb.2014.10.003_bb0200","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1136\/bmj.324.7352.1512","article-title":"Folic acid, ageing, depression, and dementia","volume":"324","author":"Reynolds","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.pbb.2014.10.003_bb0205","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1753-4887.2009.00180.x","article-title":"Major depressive disorder and nutritional medicine: a review of monotherapies and adjuvant treatments","volume":"67","author":"Sarris","year":"2009","journal-title":"Nutr Rev"},{"key":"10.1016\/j.pbb.2014.10.003_bb0210","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2826.2004.01195.x","article-title":"Gonadectomy reverses the sexually diergic patterns of circadian and stress-induced hypothalamic\u2013pituitary\u2013adrenal axis activity in male and female rats","volume":"16","author":"Seale","year":"2004","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.pbb.2014.10.003_bb0215","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.pnpbp.2010.03.005","article-title":"Behavioral and neurobiological consequences of prolonged glucocorticoid exposure in rats: relevance to depression","volume":"34","author":"Sterner","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2014.10.003_bb0220","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2014.10.003_bb0225","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.arr.2005.03.003","article-title":"The stress system in the human brain in depression and neurodegeneration","volume":"4","author":"Swaab","year":"2005","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.pbb.2014.10.003_bb0230","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/da.22217","article-title":"Major depressive disorder in DSM-5: implications for clinical practice and research of changes from DSM-IV","volume":"31","author":"Uher","year":"2014","journal-title":"Depression Anxiety"},{"key":"10.1016\/j.pbb.2014.10.003_bb0235","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000087097","article-title":"Chronic mild stress (CMS) revisited: consistency and behavioural\u2013neurobiological concordance in the effects of CMS","volume":"52","author":"Willner","year":"2005","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pbb.2014.10.003_bb0240","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/35072566","article-title":"Research and treatment approaches to depression","volume":"2","author":"Wong","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pbb.2014.10.003_bb0245","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.psyneuen.2012.09.011","article-title":"Mineralocorticoid receptor antagonist spironolactone prevents chronic corticosterone induced depression-like behavior","volume":"38","author":"Wu","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pbb.2014.10.003_bb0250","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejphar.2007.12.005","article-title":"A mouse model of depression induced by repeated corticosterone injections","volume":"581","author":"Zhao","year":"2008","journal-title":"Eur J Pharmacol"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305714002779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305714002779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T11:56:22Z","timestamp":1538135782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305714002779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":50,"alternative-id":["S0091305714002779"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2014.10.003","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Folic acid prevents depressive-like behavior induced by chronic corticosterone treatment in mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2014.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}